Company press releases

Displaying 1 - 50 of 208 results
Released Company Title Industry Topic
02 Jun 2026
14:30 CEST 		INVENTIVA Inventiva annonce la reprise des négociations de ses actions ordinaires sur Euronext Paris   20103010 Biotechnology Other subject
02 Jun 2026
14:30 CEST 		INVENTIVA Inventiva Announces Trading Resumption of its Ordinary Shares on Euronext Paris 20103010 Biotechnology Other subject
02 Jun 2026
14:29 CEST 		INVENTIVA Inventiva annonce une optimisation globale de sa structure financière, comprenant un financement obligataire et une offre d'American Depositary Shares, en prévision de la publication attendue des résultats de l'essai de phase 3 20103010 Biotechnology Other subject
02 Jun 2026
14:29 CEST 		INVENTIVA Inventiva Announces a Comprehensive Capital Structure Optimization including Debt and Equity Financing in Advance of the Anticipated Phase 3 Readout 20103010 Biotechnology Other subject
02 Jun 2026
07:30 CEST 		INVENTIVA Inventiva annonce la suspension temporaire du cours de ses actions ordinaires sur Euronext Paris 20103010 Biotechnology Other subject
02 Jun 2026
07:30 CEST 		INVENTIVA Inventiva Announces Temporary Trading Halt of its Ordinary Shares on Euronext Paris 20103010 Biotechnology Other subject
26 May 2026
22:00 CEST 		INVENTIVA Inventiva publie ses informations financières du premier trimestre 2026¹ 20103010 Biotechnology Other subject
26 May 2026
22:00 CEST 		INVENTIVA Inventiva Reports 2026 First Quarter Financial Information¹ 20103010 Biotechnology Other subject
21 May 2026
22:00 CEST 		INVENTIVA Inventiva présentera lors de la 2026 Jefferies Global Healthcare Conference 20103010 Biotechnology Other subject
21 May 2026
22:00 CEST 		INVENTIVA Inventiva to Present at 2026 Jefferies Global Healthcare Conference   20103010 Biotechnology Other subject
13 May 2026
08:30 CEST 		INVENTIVA Inventiva présentera plusieurs abstracts lors de l’EASL Congress 2026 20103010 Biotechnology Meetings / events
13 May 2026
08:30 CEST 		INVENTIVA Inventiva to Present Abstracts at the EASL Congress 2026 20103010 Biotechnology Meetings / events
22 Apr 2026
22:00 CEST 		INVENTIVA Inventiva renforce son équipe de direction à l’approche des résultats de Phase 3 du lanifibranor 20103010 Biotechnology Corporate life
22 Apr 2026
22:00 CEST 		INVENTIVA Inventiva Strengthens Leadership Team Ahead of Expected Phase 3 Data Readout of Lanifibranor 20103010 Biotechnology Corporate life
08 Apr 2026
22:00 CEST 		INVENTIVA Inventiva annonce le dépôt de son Document d’Enregistrement Universel 2025 et de son Rapport Annuel 2025 (« Form 20-F ») 20103010 Biotechnology New
08 Apr 2026
22:00 CEST 		INVENTIVA Inventiva announces filing of its 2025 Universal Registration Document and 2025 Annual Report on Form 20-F 20103010 Biotechnology New
30 Mar 2026
22:11 CEST 		INVENTIVA Inventiva publie ses résultats financiers annuels 2025 et fait le point sur son activité 20103010 Biotechnology Other subject
30 Mar 2026
22:11 CEST 		INVENTIVA Inventiva reports 2025 full year results and provides a business update 20103010 Biotechnology Other subject
23 Mar 2026
22:00 CET 		INVENTIVA Inventiva Schedules the Publication and Presentation of its 2025 Full-Year Financial Results   20103010 Biotechnology Other subject
23 Mar 2026
22:00 CET 		INVENTIVA Inventiva annonce la publication et la présentation de ses résultats financiers annuels 2025 20103010 Biotechnology Other subject
26 Feb 2026
22:14 CET 		INVENTIVA Inventiva to Participate in Four Upcoming March Investor Conferences 20103010 Biotechnology -
26 Feb 2026
22:14 CET 		INVENTIVA Inventiva participera à quatre conférences investisseurs en mars 20103010 Biotechnology -
26 Feb 2026
22:00 CET 		INVENTIVA Inventiva to Participate in Four Upcoming March Investor Conferences 20103010 Biotechnology -
26 Feb 2026
22:00 CET 		INVENTIVA Inventiva to Participate in Four Upcoming March Investor Conferences 20103010 Biotechnology -
17 Feb 2026
08:30 CET 		INVENTIVA Inventiva publie ses résultats financiers préliminaires pour l’exercice 2025¹ 20103010 Biotechnology Other subject
17 Feb 2026
08:30 CET 		INVENTIVA Inventiva reports preliminary 2025¹ fiscal year financial results 20103010 Biotechnology Other subject
04 Feb 2026
22:00 CET 		INVENTIVA Inventiva présentera au Guggenheim Emerging Outlook : Biotech Summit 2026 20103010 Biotechnology Meetings / events
04 Feb 2026
22:00 CET 		INVENTIVA Inventiva to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026 20103010 Biotechnology Meetings / events
26 Jan 2026
22:00 CET 		INVENTIVA Bilan semestriel du contrat de liquidité de la société Inventiva conclu avec Kepler Cheuvreux 20103010 Biotechnology New
26 Jan 2026
22:00 CET 		INVENTIVA Half-Year Review of Inventiva’s Liquidity Contract with Kepler Cheuvreux 20103010 Biotechnology New
17 Dec 2025
22:00 CET 		INVENTIVA Inventiva to Present at the 44th Annual J.P. Morgan Healthcare Conference 20103010 Biotechnology Other subject
17 Dec 2025
22:00 CET 		INVENTIVA Inventiva présentera à la 44e conférence annuelle J.P. Morgan Healthcare   20103010 Biotechnology Other subject
28 Nov 2025
08:30 CET 		INVENTIVA Résultats des Votes de l’Assemblée Générale Mixte des Actionnaires Réunie le 27 novembre 2025 20103010 Biotechnology General meeting / Board Meeting
28 Nov 2025
08:30 CET 		INVENTIVA Results of the Votes of the Combined Shareholders’ General Meeting of November 27, 2025 20103010 Biotechnology General meeting / Board Meeting
24 Nov 2025
22:00 CET 		INVENTIVA Informations relatives aux activités de stabilisation menées dans le cadre de sa récente offre au public 20103010 Biotechnology Other subject
24 Nov 2025
22:00 CET 		INVENTIVA Information relating to the stabilization activities carried out in the context of its recent offering 20103010 Biotechnology Other subject
21 Nov 2025
22:00 CET 		INVENTIVA Inventiva publie ses informations financières du 3ème trimestre 2025¹ 20103010 Biotechnology Other subject
21 Nov 2025
22:00 CET 		INVENTIVA Inventiva reports 2025 Third Quarter Financial Information¹ 20103010 Biotechnology Other subject
17 Nov 2025
08:30 CET 		INVENTIVA Inventiva annonce l’exercice intégral de l’Option des Banques portant le montant de l'Offre à environ 172,5 millions de dollars 20103010 Biotechnology Other subject
17 Nov 2025
08:30 CET 		INVENTIVA Inventiva announces full exercise of Underwriters’ Option, bringing proceeds of Offering to approximately $172.5M 20103010 Biotechnology Other subject
13 Nov 2025
16:24 CET 		INVENTIVA Inventiva annonce la reprise des négociations de ses actions ordinaires sur Euronext Paris 20103010 Biotechnology Other subject
13 Nov 2025
16:24 CET 		INVENTIVA Inventiva announces trading resumption of its ordinary shares on Euronext Paris 20103010 Biotechnology Other subject
13 Nov 2025
15:21 CET 		INVENTIVA Inventiva annonce les modalités définitives ainsi que l'extension de l'offre au public d'American Depositary Shares d'approximativement 150 millions de dollars 20103010 Biotechnology Other subject
13 Nov 2025
15:21 CET 		INVENTIVA Inventiva announces pricing of upsized public offering of approximately $150M of American Depositary Shares 20103010 Biotechnology Other subject
13 Nov 2025
08:40 CET 		INVENTIVA Inventiva announces temporary trading halt of its ordinary shares on Euronext Paris 20103010 Biotechnology Other subject
13 Nov 2025
08:40 CET 		INVENTIVA Inventiva annonce la suspension temporaire du cours de ses actions ordinaires sur Euronext Paris 20103010 Biotechnology Other subject
12 Nov 2025
22:25 CET 		INVENTIVA Inventiva announces launch of public offering 20103010 Biotechnology Other financial transaction
12 Nov 2025
22:25 CET 		INVENTIVA Inventiva annonce le lancement d'une offre au public 20103010 Biotechnology Other financial transaction
06 Nov 2025
22:00 CET 		INVENTIVA Assemblée Générale Mixte du 27 novembre 2025 - Modalités de mise à disposition des documents préparatoires 20103010 Biotechnology Other subject
06 Nov 2025
22:00 CET 		INVENTIVA Combined General Meeting of November 27, 2025 - Availability of the preparatory documents 20103010 Biotechnology Other subject